Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

TD Cowen analyst Charles Rhyee maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $250.00. The ...

TD Cowen analyst William Katz maintained a Hold rating on Affiliated Managers (AMG – Research Report) today and set a price target of $187.00.

Apple ( AAPL) supplier Skyworks Solutions ( SWKS) saw its stock drop nearly 25% Thursday as the semiconductor firm said that ...

(Reuters) - U.S. energy firms this week added oil and natural gas rigs for a second week in a row for the first time since ...

TD Cowen expressed confidence in Pinterest Inc (NYSE:PINS), increasing the company's price target from $38.00 to $46.00 while maintaining a Buy rating. The decision came on the heels of Pinterest's ...

Fintel reports that on January 5, 2025, TD COWEN upgraded their outlook for Bank of Nova Scotia (NYSE:BNS) from Hold to Buy. Analyst Price Forecast Suggests 9.31% Upside As of December 24 ...

CFO Jay Malave will participate in a fireside chat at the TD Cowen 46th Annual Aerospace & Defense Conference on Thursday, Feb. 13 at 8:30 a.m. to 9:10 a.m. ET.

HSA Bank, a division of Webster Bank, N.A., today announced the launch of its new visual brand identity and logo, marking a ...

Why are we forgetting history's lessons? We're told in school that we study history so as not to repeat its mistakes. But what if those lessons aren't sticking? Today's guest regularly invokes ...

Ippei Mizuhara, who last year agreed to plead guilty to bank fraud in connection with illegally transferring millions of dollars from Shohei Ohtani, is allegedly heard in a newly released ...